ATE381343T1 - Verwendung eines wachstumshormons oder eines wachstumshormon-sekretion fördernden mittels zur appetit-unterdrückung bzw. sättigungsinduktion - Google Patents

Verwendung eines wachstumshormons oder eines wachstumshormon-sekretion fördernden mittels zur appetit-unterdrückung bzw. sättigungsinduktion

Info

Publication number
ATE381343T1
ATE381343T1 AT00972638T AT00972638T ATE381343T1 AT E381343 T1 ATE381343 T1 AT E381343T1 AT 00972638 T AT00972638 T AT 00972638T AT 00972638 T AT00972638 T AT 00972638T AT E381343 T1 ATE381343 T1 AT E381343T1
Authority
AT
Austria
Prior art keywords
agent
appetite suppression
saturation induction
growth hormone
promotes
Prior art date
Application number
AT00972638T
Other languages
English (en)
Inventor
Kjell Malmloef
Hanne Jepsen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Application granted granted Critical
Publication of ATE381343T1 publication Critical patent/ATE381343T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/26—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
AT00972638T 1999-11-03 2000-10-27 Verwendung eines wachstumshormons oder eines wachstumshormon-sekretion fördernden mittels zur appetit-unterdrückung bzw. sättigungsinduktion ATE381343T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA199901585 1999-11-03

Publications (1)

Publication Number Publication Date
ATE381343T1 true ATE381343T1 (de) 2008-01-15

Family

ID=8106297

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00972638T ATE381343T1 (de) 1999-11-03 2000-10-27 Verwendung eines wachstumshormons oder eines wachstumshormon-sekretion fördernden mittels zur appetit-unterdrückung bzw. sättigungsinduktion

Country Status (7)

Country Link
US (2) US20030105005A1 (de)
EP (1) EP1229927B1 (de)
JP (1) JP2003534237A (de)
AT (1) ATE381343T1 (de)
AU (1) AU1130501A (de)
DE (1) DE60037535D1 (de)
WO (1) WO2001032200A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2686899B1 (fr) 1992-01-31 1995-09-01 Rhone Poulenc Rorer Sa Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
EP2213743A1 (de) 2000-04-12 2010-08-04 Human Genome Sciences, Inc. Albuminfusionsproteine
WO2003004068A1 (en) * 2001-07-06 2003-01-16 Auckland Uniservices Limited Hypertension treatment
WO2005003296A2 (en) 2003-01-22 2005-01-13 Human Genome Sciences, Inc. Albumin fusion proteins
AU2002364586A1 (en) 2001-12-21 2003-07-30 Delta Biotechnology Limited Albumin fusion proteins
KR20050071498A (ko) * 2002-09-18 2005-07-07 상트르 오스피딸리에 드 루니버시떼 드 몬트리알 성장 호르몬 방출 호르몬 유사체

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3856942A (en) * 1973-05-10 1974-12-24 P Murphy Appetite control composition
US4863901A (en) * 1986-01-09 1989-09-05 Brigham & Women's Hospital Use of growth hormone for nitrogen retention under hypocaloric conditions
DK472189A (da) * 1988-09-29 1990-03-30 Bunge Australia Vaeksthormon
US5126324A (en) * 1990-06-07 1992-06-30 Genentech, Inc. Method of enhancing growth in patients using combination therapy
AU693478B2 (en) * 1994-11-10 1998-07-02 Metabolic Pharmaceuticals Limited Treatment of obesity
US5912229A (en) * 1996-03-01 1999-06-15 Novo Nordisk Als Use of a pharmaceutical composition comprising an appetite-suppressing peptide
SE9601397D0 (sv) * 1996-04-12 1996-04-12 Pharmacia Ab Use of growth hormone
US5652301A (en) * 1996-08-20 1997-07-29 Bayer Corporation Aqueous polyurea dispersions and their use for preparing coatings with excellent hydrolytic and thermal stability
US6458924B2 (en) * 1996-08-30 2002-10-01 Novo Nordisk A/S Derivatives of GLP-1 analogs
DE69732572T2 (de) * 1996-11-12 2005-12-29 Novo Nordisk A/S Verwendung von glp-1 peptiden
US5952301A (en) * 1996-12-10 1999-09-14 1149336 Ontario Inc. Compositions and methods for enhancing intestinal function
US6051557A (en) * 1997-05-16 2000-04-18 1149336 Ontario Inc. Methods of enhancing functioning of the upper gastrointestinal tract
ATE314371T1 (de) * 1998-11-10 2006-01-15 Merck & Co Inc Spiro-indole als y5-rezeptor antagonisten

Also Published As

Publication number Publication date
EP1229927B1 (de) 2007-12-19
EP1229927A1 (de) 2002-08-14
US20030105005A1 (en) 2003-06-05
DE60037535D1 (de) 2008-01-31
US20050171003A1 (en) 2005-08-04
AU1130501A (en) 2001-05-14
JP2003534237A (ja) 2003-11-18
WO2001032200A1 (en) 2001-05-10

Similar Documents

Publication Publication Date Title
ATE332674T1 (de) Inkontinenzband zur behandlung der harninkontinenz
DE69227103D1 (de) Implantierbare gewebegrundlage und verfahren zur reduzierung der immunogenität
ATE358462T1 (de) Vorrichtung zur befestigung von weichgewebe an einer kunstprothese
GB0516718D0 (en) Method for the automatic plotting of pressure-volume curves during artificial respiration
ATE211634T1 (de) Orthopädische vorrichtung zur allmählichen korrektur von gliedern
ATE381343T1 (de) Verwendung eines wachstumshormons oder eines wachstumshormon-sekretion fördernden mittels zur appetit-unterdrückung bzw. sättigungsinduktion
ATE302181T1 (de) Verbindungen zur stimulation der sekretion von wachstumshormonen
ATE466582T1 (de) 16-phenoxy-lipoxin analoge zur medizinischen verwendung
ATE328476T1 (de) Verfahren zur verbesserung der reproduktionsleistung bei geflügel
DE60223611D1 (de) Mehrflügeliger Ballonkatheter zur Verminderung von Schäden an beschichteten expandierbaren medizinischen Implantaten
ATE523221T1 (de) Systeme und verfahren für die bilaterale stimulierung von linken und rechten ästen der dorsalen genitalnerven zur behandlung von funktionsstörungen, wie z.b. harninkontinenz
ATE313326T1 (de) VERWENDUNG VON CABERGOLIN ZUR BEHANDLUNG VON ßRESTLESS LEGS SYNDROMß
AU7574601A (en) Tissue implant
ATE361107T1 (de) Verfahren zur beschichtung von implantaten mittels eines druckverfahrens
DE60318052D1 (de) Implantierbare prothese
DE60336298D1 (de) Medizinische implantierbare vorrichtung zur verminderung der effekten von magnetresonanz
PL1656164T3 (pl) Powlekane implanty i sposoby powlekania
SG132498A1 (en) Beta-l-2æ-deoxy-nucleosides for the treatment of hepatitis b
DE60104756D1 (de) Oberflächenmontierte Antenne, Verfahren zur Justierung und Einstellung der Zweifrequenzresonanz der Antenne und Kommunikationsgerät mit einer derartigen Antenne
DE59902605D1 (de) Verfahren zur binauralen anpassung von hörgeräten
DK1119393T3 (da) Elektromagnetisk stimulering af bruskvæv ved anvendelse af FGF
DK1210951T3 (da) Præparat indeholdende östrogen-agonister/antagonister og testosteron til behandling af et fald i niveauet af hormonet testosteron
AR021286A1 (es) Un metodo de tratamiento de tumores en mamiferos mediante la administracion de compuestos que inducen la liberacion de la hormona del crecimiento y susantagonistas
DE60328859D1 (de) Bildverarbeitungsvorrichtung und Verfahren zur Konstrastverstärkung mittels Histogrammausgleich
ATE332688T1 (de) Verwendung von carbinolen zur behandlung von neuropathischer funktionsstörung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties